MedTrace Logo

The Impact of a Tobacco Control Intervention in African-American Families

NCT01164306 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 688

Last updated 2015-02-02

No results posted yet for this study

Summary

The purpose of this randomized control trial is to evaluate the effects of a multi-component intervention aimed at:

1. preventing tobacco initiation in youth
2. promoting anti-tobacco socialization in the home
3. decreasing environmental tobacco smoke exposure in children
4. promoting successful cessation in parent/guardian smokers.

Control arm participants receive general health education. This family-based approach is implemented with school systems as the primary point of entry.

Conditions

  • Tobacco Prevention
  • Environmental Tobacco Smoke Exposure
  • Tobacco Cessation

Interventions

BEHAVIORAL

LifeSkills Training

LifeSkills Training (Botvin's) is an evidenced based substance abuse prevention program for elementary school students to learn skills to resist tobacco, alcohol, drug abuse, and violence. Parent LifeSkills will also be utilized. Parents are provided a parent manual and DVD to use at home with their child to reinforce what they are taught in school-based LifeSkills sessions.

BEHAVIORAL

Healthy Lifestyle Behavior Choices

The healthy lifestyle behavior choices curriculum augments the state health curriculum in the assigned study schools. Parents will also be given health related information by mail to parallel the information students receive in school health classes.

BEHAVIORAL

NRT and Motivational Interviewing (MI)

For parent/guardian smokers who want to quit, NRT is offered in conjunction with MI.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Augusta University

    lead OTHER

Principal Investigators

  • Martha S Tingen, PhD · Augusta University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
8 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2012-05-31
Completion
2014-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01164306 on ClinicalTrials.gov